IL13RA2 and central nervous system cancer: In a glioma model, an IL13Rα2 specific CAR T cell that also had transgenic expression of IL-15 successfully killed tumor, proliferated, and produced cytokine in vivo; however, recurrent tumors demonstrated IL13Rα2 downregulation (84).